FTO and COVID-19: The FTO GG genotype remained associated with an increased risk of COVID-19 mortality both before and after multiple adjustments, with an adjusted odds ratio of 2.01 (95% confidence interval; 1.19-3.41, P <0.01) compared with survivors (Table 3).